Truist Financial Boosts UnitedHealth Group (NYSE:UNH) Price Target to $480.00

UnitedHealth Group (NYSE:UNH) had its price target hoisted by stock analysts at Truist Financial from $440.00 to $480.00 in a report issued on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the healthcare conglomerate’s stock. Truist Financial’s price target would indicate a potential upside of 11.72% from the stock’s previous close.

UNH has been the subject of several other research reports. Barclays boosted their price target on UnitedHealth Group from $373.00 to $429.00 and gave the stock an “overweight” rating in a research note on Tuesday, May 26th. TD Cowen reaffirmed a “hold” rating on shares of UnitedHealth Group in a report on Tuesday. UBS Group upped their price target on UnitedHealth Group from $410.00 to $460.00 and gave the stock a “buy” rating in a research report on Friday, May 22nd. Mizuho lifted their price objective on UnitedHealth Group from $440.00 to $460.00 and gave the company an “outperform” rating in a research report on Monday, June 8th. Finally, JPMorgan Chase & Co. raised their target price on shares of UnitedHealth Group from $420.00 to $466.00 and gave the stock an “overweight” rating in a research note on Monday, June 8th. One equities research analyst has rated the stock with a Strong Buy rating, twenty have assigned a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $425.62.

UnitedHealth Group Stock Performance

Shares of UNH opened at $429.64 on Tuesday. The stock’s fifty day moving average price is $400.56 and its two-hundred day moving average price is $339.71. UnitedHealth Group has a 1 year low of $234.60 and a 1 year high of $434.30. The firm has a market cap of $390.17 billion, a PE ratio of 32.54, a PEG ratio of 1.71 and a beta of 0.62. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.80 and a quick ratio of 0.80.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 earnings per share for the quarter, topping the consensus estimate of $6.76 by $0.47. UnitedHealth Group had a net margin of 2.68% and a return on equity of 14.65%. The firm had revenue of $111.65 billion for the quarter, compared to analysts’ expectations of $109.84 billion. During the same quarter in the prior year, the firm posted $7.20 earnings per share. The business’s quarterly revenue was up 2.0% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. On average, equities research analysts forecast that UnitedHealth Group will post 18.32 EPS for the current year.

Insiders Place Their Bets

In other news, CEO Patrick Hugh Conway sold 800 shares of the stock in a transaction on Thursday, April 23rd. The stock was sold at an average price of $355.00, for a total transaction of $284,000.00. Following the completion of the sale, the chief executive officer owned 17,805 shares in the company, valued at approximately $6,320,775. This represents a 4.30% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.28% of the stock is currently owned by corporate insiders.

Institutional Trading of UnitedHealth Group

Hedge funds have recently added to or reduced their stakes in the company. Norges Bank purchased a new stake in shares of UnitedHealth Group in the 4th quarter valued at approximately $4,376,167,000. T. Rowe Price Investment Management Inc. increased its holdings in UnitedHealth Group by 141.9% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 4,109,029 shares of the healthcare conglomerate’s stock valued at $1,356,432,000 after buying an additional 2,410,128 shares during the last quarter. Cardano Risk Management B.V. boosted its position in shares of UnitedHealth Group by 864.4% during the 4th quarter. Cardano Risk Management B.V. now owns 2,523,700 shares of the healthcare conglomerate’s stock worth $833,099,000 after acquiring an additional 2,262,006 shares in the last quarter. Bank of America Corp DE raised its position in shares of UnitedHealth Group by 21.8% during the 1st quarter. Bank of America Corp DE now owns 11,713,684 shares of the healthcare conglomerate’s stock worth $3,169,606,000 after acquiring an additional 2,097,859 shares in the last quarter. Finally, Hsbc Holdings PLC boosted its holdings in UnitedHealth Group by 87.5% in the fourth quarter. Hsbc Holdings PLC now owns 3,916,041 shares of the healthcare conglomerate’s stock valued at $1,294,367,000 after purchasing an additional 1,826,948 shares in the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group News Roundup

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: KeyCorp raised its price target on UnitedHealth Group to $475 from $400 and reiterated an overweight rating, signaling confidence in further upside from current levels.
• Positive Sentiment: Wells Fargo also lifted its target to $485 from $397 with an overweight rating, adding to the bullish analyst sentiment heading into earnings.
• Positive Sentiment: Investors are positioning for UnitedHealth’s quarterly results to potentially support a move toward new highs, with expectations elevated after a strong run and improved technical momentum.
• Positive Sentiment: UnitedHealth is investing $1.5 billion in AI as part of its turnaround strategy, which could improve efficiency and margins if management delivers on its projected return.
• Neutral Sentiment: Market chatter suggests the stock could see a sizable post-earnings move, with options pricing and volatility indicating traders are bracing for a meaningful reaction to the report.
• Neutral Sentiment: Analysts are watching for signs that UnitedHealth can manage medical costs and membership trends, which will be key to judging whether the current rebound can continue.
• Negative Sentiment: Some commentary warns that the stock’s sharp rally and near-term technical setup could leave it vulnerable if earnings or guidance disappoint.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.